In this free webinar, learn why the agile clinical trial model is a great fit for many rare disease categories. Attendees will learn how agile clinical trials are intrinsically patient-focused, how to maximize patient involvement and what successful enrollment looks like for an agile clinical trial in a rare disease category. The featured speakers will discuss how to navigate the regulatory landscape for agile clinical trials in rare diseases. The speakers will also discuss how to design studies that are safe, appropriate and reliable so they can generate data to meet the endpoints. The speakers will present case studies and appropriate use cases for agile clinical trials in rare disease categories.
TORONTO, Sept. 13, 2022 /PRNewswire-PRWeb/ -- The agile clinical trial of the future, comprising a bespoke mix of traditional and decentralized components, has the potential to transform and accelerate the development of treatments for rare diseases. Advanced enrollment techniques bring clinical trials to the diagnosed patients who need them most, while also increasing the diversity of study populations. Meanwhile, the replacement of numerous clinic-based activities with home visits and remote digital tools greatly reduces the burden on participants and creates a highly patient-focused environment.
Science 37's research shows that rare diseases will be among the most prevalent categories for incorporating decentralized approaches into future clinical trial designs.
This webinar will explore why the agile clinical trial model is potentially a great fit for many rare disease categories. Attendees will learn how agile clinical trials are intrinsically patient-focused and how to maximize engagement. Attendees will learn what successful enrollment looks like for an agile clinical trial in a rare disease category.
The featured speakers will discuss how to navigate the regulatory landscape for agile clinical trials in rare diseases. The speakers will also discuss how to design studies that are safe, appropriate and reliable so they can generate data to meet the endpoints. The speakers will present case studies and appropriate use cases for agile clinical trials in rare disease categories.
Join this webinar to learn about accelerating rare disease research with agile clinical trials.
Join experts from Science 37, Debra Weinstein, MD, CMI, Vice President, Internal Medicine; Suzanne Pendl, Senior Director, Medical Affairs; moderator James Chase, Senior Director, Thought Leadership; and Britanny Groner, Associate Director from BridgeBio, for the live webinar on Tuesday, October 4, 2022, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit How Agile Clinical Trials Unlock Universal Access to Rare Disease Research.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article